Literature DB >> 29622940

Plecanatide (Trulance) for Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation.

Julia A Kamuda, Nissa Mazzola.   

Abstract

Plecanatide (Trulance) for chronic idiopathic constipation and irritable bowel syndrome with constipation.

Entities:  

Year:  2018        PMID： 29622940      PMCID： PMC5871240     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  5 in total

1.  The treatment of chronic constipation in adults. A systematic review.

Authors:  S M Tramonte; M B Brand; C D Mulrow; M G Amato; M E O'Keefe; G Ramirez
Journal:  J Gen Intern Med       Date:  1997-01       Impact factor: 5.128

Review 2.  American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation.

Authors:  Alexander C Ford; Paul Moayyedi; Brian E Lacy; Anthony J Lembo; Yuri A Saito; Lawrence R Schiller; Edy E Soffer; Brennan M R Spiegel; Eamonn M M Quigley
Journal:  Am J Gastroenterol       Date:  2014-08       Impact factor: 10.864

Review 3.  Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis.

Authors:  Nicole C Suares; Alexander C Ford
Journal:  Am J Gastroenterol       Date:  2011-05-24       Impact factor: 10.864

4.  Effect of increased fluid intake on stool output in normal healthy volunteers.

Authors:  B D Chung; U Parekh; J H Sellin
Journal:  J Clin Gastroenterol       Date:  1999-01       Impact factor: 3.062

5.  Association between physical activity, fiber intake, and other lifestyle variables and constipation in a study of women.

Authors:  Laurent Dukas; Walter C Willett; Edward L Giovannucci
Journal:  Am J Gastroenterol       Date:  2003-08       Impact factor: 10.864
  5 in total
  2 in total

Review 1.  Pharmacokinetics of Toxin-Derived Peptide Drugs.

Authors:  David Stepensky
Journal:  Toxins (Basel)       Date:  2018-11-20       Impact factor: 4.546

2.  Abnormal Uroguanylin Immunoreactive Cells Density in the Duodenum of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Changes following Fecal Microbiota Transplantation.

Authors:  Tarek Mazzawi; Øystein Eikrem; Gülen Arslan Lied; Trygve Hausken
Journal:  Gastroenterol Res Pract       Date:  2020-02-04       Impact factor: 2.260
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.